ENHO and type 2 diabetes mellitus: The findings of the study highlighted that serum adropin levels of <2.30 ng/mL were independently associated with and accurately predicted a CRF ‐1 to 3 stage in patients suffering from type 2 diabetes mellitus (T2DM) and chronic heart failure.